What's in Rhodes Pharmaceuticals, L.P.'s pipeline?

Rhodes Pharmaceuticals, L.P. has 4 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Rhodes Pharmaceuticals, L.P.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, BRC Operations Pty. Ltd., Massachusetts General Hospital, NYU Langone Health, Novartis.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rhodes-pharmaceuticals-l-p.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Rhodes Pharmaceuticals, L.P. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rhodes Pharmaceuticals, L.P. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Aptensio XR	Aptensio XR	marketed	Sympathomimetic amine; CNS stimulant	Dopamine transporter (DAT); Norepinephrine transporter (NET)	Psychiatry/Neurology
Drug: PRC-063	Drug: PRC-063	phase 3	Stimulant; dopamine-norepinephrine reuptake inhibitor	Dopamine transporter (DAT); norepinephrine transporter (NET)	Psychiatry / Neurology
PRC-063	PRC-063	phase 3	Stimulant; dopamine and norepinephrine reuptake inhibitor	Dopamine transporter (DAT); norepinephrine transporter (NET)	Psychiatry / Neurology

Therapeutic area mix

Psychiatry / Neurology · 2
Psychiatry/Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
BRC Operations Pty. Ltd. · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
NYU Langone Health · 1 shared drug class
Novartis · 1 shared drug class
Rochester Center for Behavioral Medicine · 1 shared drug class
Rush University Medical Center · 1 shared drug class
Seattle Children's Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Rhodes Pharmaceuticals, L.P.:

Cite this brief

Drug Landscape (2026). Rhodes Pharmaceuticals, L.P. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rhodes-pharmaceuticals-l-p. Accessed 2026-05-16.